Pinnacle Wealth Advisors’s GSK GSK Stock Holding History

Pinnacle Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$546K	Buy	+10,966	New	+$527K	0.02%	262

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pinnacle Wealth Advisors's GSK Position: Q2 2021 in Review

Pinnacle Wealth Advisors opened a new position in GSK (GSK) in Q2 2021: 10,966 shares worth $546K. The stake represents 0.02% of the portfolio and ranks #262 among its holdings.

798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

Pinnacle Wealth Advisors held 10,966 shares of GSK worth $546K as of Q2 2021.
GSK was a new Pinnacle Wealth Advisors position in Q2 2021.
GSK made up 0.02% of Pinnacle Wealth Advisors's portfolio in Q2 2021, its #262 holding.
798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Pinnacle Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.